# RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/re-mind2-comparative-effectiveness-of-tafasitamab-plus-lenalidomide-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Grzegorz S. Nowakowski,Dok Hyun Yoon,Patrizia Mondello,Erel Joffe,Anthea Peters,Isabelle Fleury,Richard Greil,Matthew Ku,Reinhard Marks,Kibum Kim,Pier Luigi Zinzani,Judith Trotman,Lorenzo Sabatelli,Eva E. Waltl,Mark Winderlich,Andrea Sporchia,Nuwan Kurukulasuriya,Raúl Córdoba,Georg Heß,Gilles Salles |
| Citations | 22 |
| DOI | 10.1007/s00277-023-05196-4 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1007/s00277-023-05196-4 |
| OpenAlex ID | https://openalex.org/W4376225548 |
| PMID | 37171597 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Lorenzo Sabatelli](https://scholariq.org/researchers/lorenzo-sabatelli/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.